HROW analyst estimates
Harrow (HROW) analyst ratings, the average price target and its range, and every firm's latest call.
HROW analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 9, 2026 | Leerink Partners | Harrow initiated with an Outperform at Leerink | $45.00 |
| May 13, 2026 | Cantor Fitzgerald | Harrow price target lowered to $88 from $91 at Cantor Fitzgerald | $88.00 |
| Mar 18, 2026 | BTIG | BTIG Reiterates Buy Rating on Harrow Health (HROW) ahead of presentations | $63.00 |
| Mar 4, 2026 | H.C. Wainwright | Harrow Health (HROW) PT Raised to $70 at H.C. Wainwright | $70.00 |
| Nov 11, 2025 | Cantor Fitzgerald | Cantor Fitzgerald reiterates Overweight rating on Harrow, ups target to $94 | $94.00 |
| Sep 29, 2025 | Lake Street | Harrow price target raised to $70 from $42 at Lake Street | $70.00 |
| Sep 23, 2025 | Craig-Hallum | Harrow price target raised to $64 from $54 at Craig-Hallum | $64.00 |
| Aug 13, 2025 | H.C. Wainwright | Harrow price target raised to $64 from $60 at H.C. Wainwright | $64.00 |
| Jul 11, 2025 | Cantor Fitzgerald | Harrow initiated with an Overweight at Cantor Fitzgerald amid path to growth | $76.00 |
| Oct 18, 2024 | B.Riley Financial | Harrow Health (HROW) PT Raised to $73 at B.Riley | $73.00 |
| Oct 4, 2024 | Lake Street | Harrow price target raised to $55 from $45 at Lake Street | $55.00 |
| Aug 9, 2024 | Craig-Hallum | Harrow price target raised to $45 from $30 at Craig-Hallum | $45.00 |
| Jun 21, 2024 | Craig-Hallum | Harrow price target raised to $30 from $26 at Craig-Hallum | $30.00 |
| Jun 3, 2024 | Lake Street | Harrow price target raised to $25 from $20 at Lake Street | $25.00 |
| Jun 3, 2024 | Loop Capital Markets | Harrow Health (HROW) PT Raised to $25 at Lake Street Capital Markets | $25.00 |
- 6 firms rate HROW: 6 buy, 0 hold, 0 sell.
- The average price target is $66.50 from 2 analysts, from $45.00 to $88.00.
Updated 2026-11-03 11:31 UTC